Unicycive Therapeutics Inc (UNCY) Live Share Price, Invest From India

Unicycive Therapeutics Inc Stock Performance

as on March 4, 2026 at 6:09 am IST

Day's Low
Day's High
$6.71
Day's Price Range
$7.05
$6.89
2.61%
Downside
2.32%
Upside
52 Week's Low
52 Week's High
$3.71
52-Week Price Range
$11.00
$6.89
46.15%
Downside
59.65%
Upside

Unicycive Therapeutics Inc share price movements today

Previous Close: $6.99
Open: $6.83
Volume: 328.1K
Day's Low - High: $6.71 - $7.05
52 Week Low - High: $3.71 - $11.00

Unicycive Therapeutics Inc Historical Returns

1 Month Return: + 1.01 %
3 Month Return: + 13.29 %
1 Year Return: + 34.32 %
3 Year Return: + 42.65 %
5 Year Return: 0 %

Unicycive Therapeutics Inc Stock Fundamentals & Key Indicators

Check Unicycive Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$148.9M

EPS (TTM)

-1.2638

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.06

Industry PE ratio

PEG Ratio

EBITDA

-31.5M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-102.29%

Unicycive Therapeutics Inc Stock Valuation

Track how Unicycive Therapeutics Inc P/E has moved over time to understand its valuation trends.

Unicycive Therapeutics Inc in the last 5 years

Overview
Trends

Lowest (-84.37x)

September 30, 2021

Industry (0.00x)

March 3, 2026

Today (-1.06x)

March 3, 2026

Highest (-3.43x)

September 30, 2024

LowHigh

Today’s Price to Earnings Ratio: -1.06x

Unicycive Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Unicycive Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Unicycive Therapeutics Inc	BUY	$148.9M	NA	-1.06	0.00%
Vertex Pharmaceuticals Incorporated	BUY	$126.2B	133.18%	32.47	32.94%
Alnylam Pharmaceuticals, Inc.	BUY	$44.2B	125.24%	142.88	8.45%
Beone Medicines Ltd	NA	$35.1B	NA	621.55	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$82.6B	77.02%	18.83	31.41%

Stock Returns calculator for Unicycive Therapeutics Inc Stock including INR - Dollar returns

The Unicycive Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Unicycive Therapeutics Inc investment value today

Current value as on today

₹1,38,005

Returns

₹38,005

(+38%)

Returns from Unicycive Therapeutics Inc Stock

₹32,500 (+32.5%)

Dollar Returns*

₹5,505 (+5.5%)

Analyst Recommendation on Unicycive Therapeutics Inc Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Unicycive Therapeutics Inc. Average target price of $46.5

Unicycive Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Unicycive Therapeutics Inc.

What analysts predicted

85.18%UPSIDE

Target Price

$46.5

Current Price

$6.89

Analyzed by

11 Analysts

Target

$46.50

Unicycive Therapeutics Inc target price $46.5, a slight upside of 85.18% compared to current price of $6.89. According to 11 analysts rating.

Unicycive Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Unicycive Therapeutics Inc Stock has increased by 74% in the last 30 days, reflecting an upward trend in search activity.

Time period: February 2, 2026 to March 4, 2026

Change:74% versus previous 30 day period

Unicycive Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	-	-	0	-	-	-	0	-	-	-
Gross Profit	0	0	0	0	-	0	0	0	0	-
Operating Income	-4	-5	-6	-9	-7	-6	-9	-7	-6	-7
EBITDA	-3	-4	-6	-20	-7	-3	-9	0	-6	-5
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-3	-4	-7	-20	9	-4	-21	0	-6	-6
Income Tax Expense	0	0	-10	0	5	-	0	-	-	-
Net Income	-3	-4	-7	-20	9	-4	-21	0	-6	-6
Net Profit Margin	0.00%	0.00%	2877.49%	0.00%	0.00%	0.00%	-3789.61%	0.00%	0.00%	0.00%

Unicycive Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	0	0	-
Gross Profit	-	-	0	0	0	0
Operating Income	-1	-2	-8	-18	-20	-32
EBITDA	-2	-2	-8	-17	-30	-36
Interest Expense	0	0	0	0	0	0
Depreciation	-	-	0	0	0	0
Income Before Tax	-2	-2	-10	-18	-30	-36
Income Tax Expense	0	0	0	0	0	-1
Net Income	-2	-2	-10	-18	-30	-36
Net Profit Margin	0.00%	0.00%	0.00%	-1899.47%	-4525.04%	0.00%

Unicycive Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-4	-7	-20	9	-4	-21	0	-6	-6
Operating Cash Flow	-4	-4	-6	-6	-9	-6	-8	-8	-5
Investing Cash Flow	-	-	0	0	0	0	0	0	0
Financing Cash Flow	0	0	45	0	0	0	2	10	26
Change in Cash	-4	-4	39	-7	-9	-6	-6	2	20

Unicycive Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-2	-2	-10	-18	-30	-36
Operating Cash Flow	-1	-1	-5	-15	-18	-28
Investing Cash Flow	0	0	0	0	0	0
Financing Cash Flow	1	1	22	0	27	45
Change in Cash	0	0	16	-16	9	16

Global Institutional Holdings in Unicycive Therapeutics Inc

Funds	Holdings
Dauntless Investment Group, LLC	0.74%
Vivo Capital, LLC	6.44%
Octagon Capital Advisors LP	5.66%
Longwood Capital Partners LLC	0.5%
Citadel Advisors Llc	0.35%

See all

Insights on Unicycive Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, -271.0K → 568.0K (in $), with an average increase of 147.7% per quarter
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, UNCY has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -6.44M → -6.01M (in $), with an average increase of 7.3% per quarter
POSITIVE IMPACT
Price Rise
In the last 6 months, UNCY stock has moved up by 62.9%
NO EFFECT
Against Peers
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 60.5% return, outperforming this stock by 17.8%

About Unicycive Therapeutics Inc

unicycive therapeutics is passionate about treating kidney diseases with significant unmet medical needs.

Organisation	Unicycive Therapeutics Inc
Headquarters	4300 El Camino Real, Los Altos, CA, United States, 94022
CEO	Dr. Shalabh K. Gupta M.D., MPA
E-voting on shares	Click here to vote

Key Management of Unicycive Therapeutics Inc

Name	Title
Dr. Shalabh K. Gupta M.D., MPA	Founder, Chairman, CEO & President
Dr. Pramod Gupta Ph.D.	Executive Vice President of Operations
Mr. Douglas Jermasek M.B.A.	Executive Vice President of Corporate Strategy
Mr. John W. Townsend CPA	Chief Financial Officer

FAQs

What is Unicycive Therapeutics Inc share price today?

Unicycive Therapeutics Inc share price today is $6.89 as on March 4, 2026 at 12:39 am IST. Unicycive Therapeutics Inc share today touched a day high of $7.05 and a low of $6.71.

What is the 52 week high and 52 week low for Unicycive Therapeutics Inc share?

Unicycive Therapeutics Inc share touched a 52 week high of $11 on June 9, 2025 and a 52 week low of $3.71 on September 25, 2025. Unicycive Therapeutics Inc stock price today i.e. March 4, 2026 at 12:39 am IST is trending at $6.89,which is 37.36% down from its 52 week high and 85.71% up from its 52 week low.

What is Unicycive Therapeutics Inc's market capitalisation today?

Unicycive Therapeutics Inc market capitalisation is $0.00T as on March 4, 2026 at 12:39 am IST.

How to invest in Unicycive Therapeutics Inc Stock (UNCY) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Unicycive Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Unicycive Therapeutics Inc Shares that will get you 0.2177 shares as per Unicycive Therapeutics Inc share price of $6.89 per share as on March 4, 2026 at 12:39 am IST.

What is the minimum amount required to buy Unicycive Therapeutics Inc Stock (UNCY) from India?

Indian investors can start investing in Unicycive Therapeutics Inc (UNCY) shares with as little as ₹92.074 or $1 (as of March 4, 2026 at 12:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹920.74 in Unicycive Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on March 4, 2026 at 12:39 am IST). Based on Unicycive Therapeutics Inc share’s latest price of $6.89 as on March 4, 2026 at 12:39 am IST, you will get 1.4514 shares of Unicycive Therapeutics Inc. Learn more about fractional shares .